aplastic anemia | Aplastic Anemia & MDS International Foundation

aplastic anemia

Nikolai Podoltsev, MD, PhD

Podoltsev, Nikolai
Associate Director of the Hematology/Oncology Fellowship Program
Smilow Cancer Hospital at Yale

Dr. Podoltsev practice is focused on myeloid neoplasms including acute myelogenous leukemias (AML), myelodisplastic syndromes (MDS), myeloproliferative neoplasms (MPNs) like polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), chronic myelogenous leukemia (CML) among others. He is providing care for patients with

Thomas Prebet, MD, PhD

Prebet, Thomas
Medical Director of Hematology and Cell Therapy
Smilow Cancer Hospital at Yale

After completing his doctorate in medical hematology and oncology in Lyon, France, Dr. Prebet joined Institut Paoli-Calmettes in Marseille, France and completed a fellowship in Johns Hopkins University (Baltimore, MA, USA) as a Fullbright alumni. Dr. Prebet is currently the director of the inpatient hematology unit and the medical director of the hematology division of Yale

2020 National Patient & Family Conference (virtual)

AAMDSIF is hosting the 2020 National Patient & Family Conference ONLINE over three days, July 17 - 19, 2020. The Conference will feature three days of educational workshops, interesting speakers and support groups for patients with

Save the date!
Event Date: 
Fri, 07/17/2020 to Sun, 07/19/2020

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Author(s): 
DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, Huff CA, Swinnen LJ, Imus P, Borrello I, Wagner-Johnston N, Ambinder RF, Luznik L, Bolaños-Meade J, Fuchs EJ, Jones RJ, Brodsky RA
Primary Author: 
DeZern AE
Journal Title: 
Blood Advances
Original Publication Date: 
Apr 2020

Severe

Bone Marrow Diseases: 

Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of

Author(s): 
ElGohary G, El Fakih R, de Latour R, Risitano A, Marsh J, Schrezenmeier H, Gluckman E, Höchsmann B, Pierri F, Halkes C, Alzahrani H, De la Fuente J, Cesaro S, Alahmari A, Ahmed SO, Passweg J, Dufour C, Bacigalupo A, Aljurf M
Primary Author: 
ElGohary G
Journal Title: 
Bone Marrow Transplantation
Original Publication Date: 
Apr 2020

Bone Marrow Diseases: 

2020 Patient & Family Virtual Conference

About

Due to the coronavirus (COVID-19) pandemic, AAMDSIF made the decision to move our conferences online in order to protect the health of our patients, families, caregivers and faculty.

We would like to acknowledge the support of our many generous patients, families and caregivers as well as our corporate partners including Celgene, Alexion, Novartis, Genentech, Jazz Pharmaceuticals, Apellis and Acceleron.

Event Date: 
Sat, 04/25/2020
Conference Event Type: 

National Conference 2020 Virtual March for Marrow

We've gone VIRTUAL!
In light of the spread of the Coronavirus (COVID-19) and with the health and well-being of our patients, family members, friends and faculty as our top priority, AAMDSIF has decided to hold our March for Marrow as a VIRTUAL WALK! 

Event Date: 
Sat, 07/18/2020
Community Event Type: 

“Everything is going to be okay:” Jocelyn’s Story of Aplastic Anemia, PNH, and Survivorship

Person's Name: 
Jocelyn Boyer

Before diagnosis, Jocelyn’s life was normal, predictable. She was thriving her senior year in college, studying Public Relations. In 2008, she was working, volunteering, attending classes---all the normal activities for a 20-year-old. 

But one day that changed. Extreme fatigue set in, making it difficult to walk a single flight of stairs. At first, she dismissed the fatigue to her rigorous schedule. 

Content source: